e10vq
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2009
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 000-50132
Sterling Chemicals, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
76-0502785 |
(State or other jurisdiction of
|
|
(IRS Employer Identification No.) |
Incorporation or organization) |
|
|
|
|
|
333 Clay Street, Suite 3600
|
|
(713) 650-3700 |
Houston, Texas 77002-4109
|
|
(Registrants telephone number, |
(Address of principal executive offices)
|
|
including area code) |
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o.
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes
o No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o | Accelerated filer o | Non-accelerated filer o (Do not check if a smaller reporting company) | Smaller reporting company þ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Exchange Act). Yes o No þ.
As of April 30, 2009, Sterling Chemicals, Inc. had 2,828,460 shares of common stock
outstanding.
IMPORTANT INFORMATION REGARDING THIS FORM 10-Q
Unless otherwise indicated, references to we, us, our and ours in this Form 10-Q refer
collectively to Sterling Chemicals, Inc. and its wholly-owned subsidiaries.
Readers should consider the following information as they review this Form 10-Q:
Forward-Looking Statements
This report contains forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the United States
Securities Exchange Act of 1934, as amended, or the Exchange Act. Forward-looking statements give
our current expectations or forecasts of future events. All statements other than statements of
historical fact are, or may be deemed to be, forward-looking statements. Forward-looking
statements include, without limitation, any statement that may project, indicate or imply future
results, events, performance or achievements, and may contain or be identified by the words
expect, intend, plan, predict, anticipate, estimate, believe, should, could,
may, might, will, will be, will continue, will likely result, project, forecast,
budget and similar expressions. Statements in this report that contain forward-looking
statements include, but are not limited to, information concerning our possible or assumed future
results of operations. While our management considers these expectations and assumptions to be
reasonable, they are inherently subject to significant business, economic, competitive, regulatory
and other risks, contingencies and uncertainties, most of which are difficult to predict and many
of which are beyond our control.
Other sections of this Form 10-Q and our other filings with the Securities and Exchange
Commission, or the SEC, including, without limitation, our Annual Report on Form 10-K for the
fiscal year ended December 31, 2008, or our Annual Report, include additional factors that could
adversely affect our business, results of operations or financial performance. See Risk Factors
contained in Item 1A of Part I of our Annual Report. Given these risks and uncertainties,
investors should not place undue reliance on forward-looking statements. Forward-looking
statements included in this Form 10-Q are made only as of the date of this Form 10-Q and are not
guarantees of future performance. Although we believe that the expectations reflected in these
forward-looking statements are reasonable, such expectations may prove to be incorrect. All
written or oral forward-looking statements attributable to us, or persons acting on our behalf, are
expressly qualified in their entirety by these cautionary statements.
Document Summaries
Descriptions of documents and agreements contained in this Form 10-Q are provided in summary
form only, and such summaries are qualified in their entirety by reference to the actual documents
and agreements filed as exhibits to our Annual Report, other periodic reports we file with the SEC
or this Form 10-Q.
Access to Filings
Access to our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports
on Form 8-K, and amendments to those reports, filed with or furnished to the SEC pursuant to
Section 13(a) of the Exchange Act, as well as reports filed electronically pursuant to Section
16(a) of the Exchange Act, may be obtained through our website (http://www.sterlingchemicals.com),
at no cost, as soon as reasonably practicable after we have electronically filed such material with
the SEC. The contents of our website (or the third-party websites accessible through the various
hyperlinks) are not, and shall not be deemed to be, incorporated into this Form 10-Q.
1
STERLING CHEMICALS, INC.
INDEX
2
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of Sterling Chemicals, Inc.:
We have reviewed the accompanying condensed consolidated balance sheet of Sterling Chemicals,
Inc. and its subsidiaries (the Company) as of March 31, 2009, and the related condensed
consolidated statements of operations and cash flows for the three month periods ended March 31,
2009 and 2008. These interim financial statements are the responsibility of the Companys
management.
We conducted our reviews in accordance with the standards of the Public Company Accounting
Oversight Board (United States). A review of interim financial information consists principally of
applying analytical procedures to financial data and making inquiries of persons responsible for
financial and accounting matters. It is substantially less in scope than an audit conducted in
accordance with the standards of the Public Company Accounting Oversight Board (United States), the
objective of which is the expression of an opinion regarding the financial statements taken as a
whole. Accordingly, we do not express such an opinion.
Based on our reviews, we are not aware of any material modifications that should be made to
the accompanying condensed consolidated financial statements for them to be in conformity with
accounting principles generally accepted in the United States of America.
GRANT THORNTON LLP
Houston, Texas
May 15, 2009
3
PART I.
FINANCIAL INFORMATION
Item 1. Financial Statements
STERLING CHEMICALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(Dollars in Thousands, Except Share Data)
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
|
|
|
|
|
|
|
Revenues |
|
$ |
31,377 |
|
|
$ |
38,258 |
|
Cost of goods sold |
|
|
25,809 |
|
|
|
33,885 |
|
|
|
|
|
|
|
|
Gross profit |
|
|
5,568 |
|
|
|
4,373 |
|
Selling, general and administrative expenses |
|
|
3,883 |
|
|
|
2,418 |
|
Interest and debt related expenses |
|
|
4,003 |
|
|
|
4,213 |
|
Interest income |
|
|
(384 |
) |
|
|
(1,326 |
) |
Other income |
|
|
(1,145 |
) |
|
|
|
|
|
|
|
|
|
|
|
Loss from continuing operations before income tax |
|
|
(789 |
) |
|
|
(932 |
) |
Benefit for income taxes |
|
|
(195 |
) |
|
|
|
|
|
|
|
|
|
|
|
Loss from continuing operations |
|
$ |
(594 |
) |
|
$ |
(932 |
) |
Income
(loss) from discontinued operations, net of tax of $869 and zero |
|
|
1,622 |
|
|
|
(6,254 |
) |
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
1,028 |
|
|
$ |
(7,186 |
) |
Preferred stock dividends |
|
|
4,147 |
|
|
|
4,271 |
|
|
|
|
|
|
|
|
Net loss attributable to common stockholders |
|
$ |
(3,119 |
) |
|
$ |
(11,457 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) per share of common stock attributable to common
stockholders, basic and diluted: |
|
|
|
|
|
|
|
|
Loss from continuing operations |
|
$ |
(1.67 |
) |
|
$ |
(1.84 |
) |
Income (loss) from discontinued operations, net of tax |
|
|
0.57 |
|
|
|
(2.21 |
) |
|
|
|
|
|
|
|
Basic and diluted loss per share |
|
$ |
(1.10 |
) |
|
$ |
(4.05 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
Basic and diluted |
|
|
2,828,460 |
|
|
|
2,828,460 |
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
4
STERLING CHEMICALS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Dollars in Thousands, Except Share Data)
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
163,065 |
|
|
$ |
156,126 |
|
Accounts and other receivables, net of allowance of $18 and $18 |
|
|
17,777 |
|
|
|
23,163 |
|
Inventories, net |
|
|
5,410 |
|
|
|
5,221 |
|
Prepaid expenses and other current assets |
|
|
2,017 |
|
|
|
2,704 |
|
Assets of discontinued operations |
|
|
146 |
|
|
|
166 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
188,415 |
|
|
|
187,380 |
|
|
|
Property, plant and equipment, net |
|
|
68,151 |
|
|
|
67,811 |
|
Other assets, net |
|
|
7,476 |
|
|
|
7,838 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
264,042 |
|
|
$ |
263,029 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS DEFICIENCY IN ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
10,094 |
|
|
$ |
8,915 |
|
Accrued liabilities |
|
|
21,844 |
|
|
|
20,008 |
|
Liabilities of discontinued operations |
|
|
12,407 |
|
|
|
12,444 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
44,345 |
|
|
|
41,367 |
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
150,000 |
|
|
|
150,000 |
|
Deferred credits and other liabilities |
|
|
59,111 |
|
|
|
59,103 |
|
Long-term liabilities of discontinued operations |
|
|
32,297 |
|
|
|
35,394 |
|
Commitments and contingencies (Note 4)
|
|
|
|
|
|
|
|
|
Redeemable preferred stock |
|
|
121,754 |
|
|
|
117,607 |
|
Stockholders equity: |
|
|
|
|
|
|
|
|
Common stock, $.01 par value (shares authorized 20,000,000;
shares issued and outstanding 2,828,460) |
|
|
28 |
|
|
|
28 |
|
Additional paid-in capital |
|
|
119,689 |
|
|
|
123,740 |
|
Accumulated deficit |
|
|
(238,795 |
) |
|
|
(239,823 |
) |
Accumulated other comprehensive loss |
|
|
(24,387 |
) |
|
|
(24,387 |
) |
|
|
|
|
|
|
|
Total stockholders deficiency in assets |
|
|
(143,465 |
) |
|
|
(140,442 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders deficiency in assets |
|
$ |
264,042 |
|
|
$ |
263,029 |
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
5
STERLING CHEMICALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(Dollars in Thousands)
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
|
|
2009 |
|
|
2008 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
1,028 |
|
|
$ |
(7,186 |
) |
Adjustments to reconcile net income (loss) to net cash
provided by operating activities: |
|
|
|
|
|
|
|
|
Stock compensation expense |
|
|
96 |
|
|
|
|
|
Depreciation and amortization |
|
|
2,245 |
|
|
|
2,635 |
|
Interest amortization |
|
|
277 |
|
|
|
279 |
|
Unearned income amortization |
|
|
(3,637 |
) |
|
|
(2,125 |
) |
Gain on disposal of property, plant and equipment |
|
|
(83 |
) |
|
|
|
|
Other |
|
|
|
|
|
|
10 |
|
Change in assets/liabilities: |
|
|
|
|
|
|
|
|
Accounts and
other receivables |
|
|
5,406 |
|
|
|
72,321 |
|
Inventories |
|
|
(189 |
) |
|
|
14,900 |
|
Prepaid expenses and other current assets |
|
|
687 |
|
|
|
1,102 |
|
Other assets |
|
|
(119 |
) |
|
|
(164 |
) |
Accounts payable |
|
|
1,240 |
|
|
|
(4,303 |
) |
Accrued liabilities |
|
|
1,799 |
|
|
|
(4,905 |
) |
Other liabilities |
|
|
548 |
|
|
|
(251 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
9,298 |
|
|
|
72,313 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows used in investing activities: |
|
|
|
|
|
|
|
|
Capital expenditures for property, plant and equipment |
|
|
(2,442 |
) |
|
|
(2,037 |
) |
Net proceeds from the sale of property, plant and equipment |
|
|
83 |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities |
|
|
(2,359 |
) |
|
|
(2,037 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows provided by financing activities: |
|
|
|
|
|
|
|
|
Net cash provided by financing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash: |
|
|
6,939 |
|
|
|
70,276 |
|
Cash and cash equivalents beginning of year |
|
|
156,126 |
|
|
|
100,183 |
|
|
|
|
|
|
|
|
Cash and cash equivalents end of period |
|
$ |
163,065 |
|
|
$ |
170,459 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow information: |
|
|
|
|
|
|
|
|
Interest paid |
|
$ |
(70 |
) |
|
$ |
(128 |
) |
Interest income received |
|
|
384 |
|
|
|
1,326 |
|
Cash paid for income taxes |
|
|
|
|
|
|
404 |
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
6
STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Basis of Presentation
The accompanying unaudited interim condensed consolidated financial statements were prepared
in accordance with accounting principles generally accepted in the United States of America, or
GAAP, and reflect all adjustments (including normal recurring accruals) which, in our opinion, are
considered necessary for the fair presentation of the results for the periods presented. The
results of operations and cash flows for the periods presented are not necessarily indicative of
the results to be expected for the full year. These statements should be read in conjunction with
the audited consolidated financial statements and notes thereto included in our Annual Report.
Reclassifications
and Revisions:
During
the quarter ended March 31, 2009, we determined we had incorrectly accounted for certain
utility allocations at our Texas City facility, specifically accounting for the flow of various
waters throughout our facility. In accordance with Staff Accounting Bulletin No. 108, Considering
the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial
Statements, we evaluated the materiality of the misstatement from qualitative and quantitative
perspectives and concluded that although the misstatement was immaterial to all prior year
financial statements, its correction in the current quarter would be material. Therefore, we are
revising the condensed consolidated statement of operation and statement of cash flows for the
three-month period ended March 31, 2008, and the condensed consolidated balance sheet as of
December 31, 2008, to correct the utility allocation misstatement.
The
following table summarizes the effects of the revision on the applicable periods:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
March 31, 2008 |
|
|
(Dollars in Thousands) |
|
|
Previously |
|
|
|
|
Reported |
|
As Revised |
Statement of Operations: |
|
|
|
|
|
|
|
|
Revenues |
|
|
38,199 |
|
|
|
38,258 |
|
Cost of goods sold |
|
|
33,799 |
|
|
|
33,885 |
|
Gross profit |
|
|
4,400 |
|
|
|
4,373 |
|
Loss from continuing operations before income tax |
|
|
(905 |
) |
|
|
(932 |
) |
Loss from continuing operations |
|
|
(905 |
) |
|
|
(932 |
) |
Loss from discontinued operations, net of tax |
|
|
(6,224 |
) |
|
|
(6,254 |
) |
Net loss |
|
|
(7,129 |
) |
|
|
(7,186 |
) |
Net loss attributable to common stockholders |
|
|
(11,400 |
) |
|
|
(11,457 |
) |
|
|
|
|
|
|
|
|
|
Loss per share of common stock attributable to
common stockholders, basic and diluted: |
|
|
|
|
|
|
|
|
Loss from continuing operations |
|
|
(1.83 |
) |
|
|
(1.84 |
) |
Loss from discontinued operations, net of tax |
|
|
(2.20 |
) |
|
|
(2.21 |
) |
|
|
|
|
|
|
|
|
|
Basic and diluted loss per share |
|
|
(4.03 |
) |
|
|
(4.05 |
) |
|
|
|
|
|
|
|
|
|
Statement of Cash Flows: |
|
|
|
|
|
|
|
|
Net loss |
|
|
(7,129 |
) |
|
|
(7,186 |
) |
Change in accounts and other receivables |
|
|
72,264 |
|
|
|
72,321 |
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2008 |
|
|
(Dollars in Thousands) |
|
|
Previously |
|
|
|
|
Reported |
|
As Revised |
Balance Sheet: |
|
|
|
|
|
|
|
|
Accounts and other receivables, net of allowance |
|
|
22,080 |
|
|
|
23,163 |
|
Total current assets |
|
|
186,297 |
|
|
|
187,380 |
|
Total assets |
|
|
261,946 |
|
|
|
263,029 |
|
Accumulated deficit |
|
|
(240,906 |
) |
|
|
(239,823 |
) |
Total stockholders deficiency in assets |
|
|
(141,525 |
) |
|
|
(140,442 |
) |
Total liabilities and stockholders deficiency in assets |
|
|
261,946 |
|
|
|
263,029 |
|
In addition to the above, our valuation allowance as of December 31, 2008 decreases from $52.5
million, as previously reported, to $52.0.
2. Discontinued Operations
On September 17, 2007, we entered into a long-term exclusive styrene supply agreement and a
related railcar purchase and sale agreement with NOVA Chemicals Inc., or NOVA. Under this supply
agreement, NOVA had the exclusive right to purchase 100% of our styrene production (subject to
existing contractual commitments), the amount of styrene supplied in any particular period being at
NOVAs option. In November 2007, this supply agreement, which was subsequently assigned by NOVA to
INEOS NOVA, LLC, or INEOS NOVA, received clearance under the Hart-Scott-Rodino Act. This clearance
caused the supply agreement and the railcar agreement to become effective and triggered a $60
million payment to us from INEOS NOVA. In accordance with the terms of the supply agreement, INEOS
NOVA assumed substantially all of our contractual obligations for future styrene deliveries. After
the supply agreement became effective, INEOS NOVA nominated zero pounds of styrene under the supply
agreement for the balance of 2007 and, in response, we exercised our right to terminate the supply
agreement and permanently shut down our styrene facility. Under the supply agreement, we are
responsible for the closure costs of our styrene facility and are also restricted from reentering
the styrene business until November 2012. The restricted period of time was initially eight years.
However, effective April 1, 2008, INEOS NOVA unilaterally reduced the restricted period to five
years.
We operated our styrene facility through early December 2007 as we completed our production of
inventory and exhausted our raw materials and purchase requirements. We sold substantially all of
our remaining inventory during the first quarter of 2008. The decommissioning process was
completed by the end of 2008 and the associated costs incurred for 2007 and 2008 were $0.7 million
and $18.9 million, respectively.
In accordance with Statement of Financial Accounting Standards, or SFAS No. 144, Accounting
for the Impairment and Disposal of Long Lived Assets, we have reported the operating results of
this business as discontinued operations in our condensed consolidated financial statements. The
carrying amounts of assets and liabilities related to discontinued operations as of March 31, 2009
and December 31, 2008 were as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in Thousands) |
|
Assets of discontinued operations: |
|
|
|
|
|
|
|
|
Accounts receivable, net |
|
$ |
146 |
|
|
$ |
166 |
|
|
|
|
|
|
|
|
|
|
Liabilities of discontinued operations: |
|
|
|
|
|
|
|
|
Accrued liabilities (1) |
|
$ |
12,407 |
|
|
$ |
12,444 |
|
Deferred credits and other liabilities (1) |
|
|
32,297 |
|
|
|
35,394 |
|
|
|
|
|
|
|
|
Total |
|
$ |
44,704 |
|
|
$ |
47,838 |
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
As of March 31, 2009, represents deferred income for the
NOVA supply agreement that is being amortized over the
contractual non-compete period of five years using the
straight-line method. Accrued liabilities include the
current portion of $12.4 million and deferred credits and
other liabilities include the long-term portion of the
deferred income of $32.3 million. |
7
STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
Revenue and pre-tax losses from discontinued operations for the three-month periods ended
March 31, 2009 and March 31, 2008 are presented below:
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
|
2009 |
|
2008 |
|
|
(Dollars in Thousands) |
Revenues |
|
$ |
3,096 |
|
|
$ |
14,597 |
|
Income (loss) before income taxes |
|
|
2,491 |
|
|
|
(6,254 |
) |
3. Long-Term Debt
On March 29, 2007, we completed a private offering of $150 million aggregate principal amount
of unregistered 101/4% Senior Secured Notes due 2015, or our Secured Notes, pursuant to a Purchase
Agreement among us, Sterling Chemicals Energy, Inc., or Sterling Energy, one of our former
wholly-owned subsidiaries, and Jefferies & Company, Inc. and CIBC World Markets Corp., as initial
purchasers. In connection with that offering, we entered into an indenture, dated March 29, 2007,
among us, Sterling Energy, as guarantor, and U. S. Bank National Association, as trustee and
collateral agent. On May 6, 2008, Sterling Energy was merged with and into us. Upon consummation
of the merger, Sterling Energy no longer had independent existence and, consequently, our Secured
Notes are no longer guaranteed by Sterling Energy. Pursuant to a registration rights agreement
among us, Sterling Energy and the initial purchasers, we agreed to exchange our unregistered
Secured Notes for a new issue of substantially identical debt securities registered under the
Securities Act, to cause the registration statement for the exchange offer to become effective by
December 24, 2007, and to complete the exchange offer within 50 days of the effective date of the
registration statement. On August 30, 2007, we made an initial filing of the exchange offer
registration statement. However, the registration statement was not declared effective by December
24, 2007 and, as a result, the interest rate on our Secured Notes increased by 0.25% per annum on
each of December 25, 2007, March 24, 2008 and June 22, 2008. The registration statement was
declared effective on August 13, 2008, and the exchange offer was closed on September 19, 2008. As
a result, the interest rate on our Secured Notes reverted back to the face amount of 101/4% per annum
when the exchange offer closed. The additional interest incurred from December 25, 2007 through
the closing of the exchange offer was approximately $0.5 million and was paid on April 1 and
October 1, 2008.
Our indenture contains affirmative and negative covenants and customary events of default,
including payment defaults, breaches of covenants and certain events of bankruptcy, insolvency and
reorganization. If an event of default occurs and is continuing, other than an event of default
triggered upon certain bankruptcy events, the trustee under our indenture or the holders of at
least 25% in principal amount of our outstanding Secured Notes may declare our Secured Notes to be
due and payable immediately. Upon an event of default, the trustee may also take actions to
foreclose on the collateral securing our outstanding Secured Notes, subject to the terms of an
intercreditor agreement dated March 29, 2007, among us, Sterling Energy, the trustee and The CIT
Group/Business Credit, Inc. Our indenture does not require us to maintain any financial ratios or
satisfy any financial maintenance tests. We are currently in compliance with all of the covenants
contained in our indenture.
Interest is due on our outstanding Secured Notes on April 1 and October 1 of each year. Our
outstanding Secured Notes, which mature on April 1, 2015, are senior secured obligations and rank
equally in right of payment with all of our existing and future senior indebtedness. Subject to
specified permitted liens, our outstanding Secured Notes are secured (i) on a first priority basis,
by all of our fixed assets and certain related assets, including, without limitation, all property,
plant and equipment and (ii) on a second priority basis, by our other assets, including, without
limitation, accounts receivable, inventory, capital stock of our domestic restricted subsidiaries,
intellectual property, deposit accounts and investment property.
On December 19, 2002, we entered into a Revolving Credit Agreement, or our revolving credit
facility, with The CIT Group/Business Credit, Inc., as administrative agent and a lender, and
certain other lenders. Under our revolving credit facility, we and Sterling Energy were
co-borrowers and were jointly and severally liable for any indebtedness thereunder. After the
merger of Sterling Energy with and into us, Sterling Energy ceased to be a co-borrower under our
revolving credit facility. Our revolving credit facility is secured by first priority liens on all
of our accounts receivable, inventory and other specified assets. On March 29, 2007, we amended
and restated our revolving credit facility to, among other things, extend the term of our revolving
credit facility until March 29, 2012, reduce the maximum commitment thereunder to $50 million, make
certain changes to the calculation of the borrowing base and lower the interest rates and fees
charged thereunder. Borrowings under our revolving credit
8
STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
facility bear interest, at our option,
at an annual rate of a base rate plus 0.0% to 0.50% or the LIBOR rate plus 1.50% to 2.25%,
depending on our borrowing availability at the time. We are also required to pay an aggregate commitment fee of 0.375% per year (payable monthly) on any unused portion of our revolving
credit facility. Available credit under our revolving credit facility is subject to a borrowing
base calculation that is updated monthly and consists of 70% of eligible accounts receivable plus
65% of eligible inventory. In response to the expected continued lower levels of accounts
receivable and inventory, as well as our lesser need for a working capital facility, we reduced our
commitment under our revolving credit facility to $25 million on June 30, 2008. On November 7,
2008, we further amended our revolving credit facility to substantially reduce restrictions,
subject to minimum liquidity requirements, on investment of cash and other assets, payment of cash
dividends, repurchase of debt and equity securities, modification of preferred stock terms, entry
into affiliated transactions, disposition of assets and engagement in certain business activities.
We paid the administrative agent under our revolving credit facility an amendment fee plus expenses
totaling approximately $0.1 million in connection with this amendment.
As of March 31, 2009, total credit available under our revolving credit facility was limited
to $10.1 million, there were no loans outstanding and we had $3.9 million in letters of credit
outstanding, resulting in borrowing availability of $6.2 million. Pursuant to Emerging Issues Task
Force Issue No. 95-22, Balance Sheet Classification of Borrowings under Revolving Credit
Agreements That Include both a Subjective Acceleration Clause and a Lock-Box Arrangement, any
balances outstanding under our revolving credit facility would be classified as a current portion
of long-term debt.
Our revolving credit facility contains numerous covenants and conditions, including, but not
limited to, restrictions on our ability to incur indebtedness, create liens, sell assets, make
investments of cash and other assets, make capital expenditures, engage in mergers and acquisitions
and pay cash dividends. Our revolving credit facility also includes various circumstances and
conditions that would, upon their occurrence and subject in certain cases to notice and grace
periods, create an event of default thereunder. Our revolving credit facility does not require us
to maintain any financial ratios or satisfy any financial maintenance tests. We are currently in
compliance with all of the covenants contained in our revolving credit facility.
4. Commitments and Contingencies
Product Contracts:
We have long-term agreements which provide for the dedication of 100% of our production of
acetic acid and plasticizers, each to one customer. See Note 7 for more information.
Environmental Regulations:
Our operations involve the handling, production, transportation, treatment and disposal of
materials that are classified as hazardous or toxic and that are extensively regulated by
environmental and health and safety laws, regulations and permit requirements. Environmental
permits required for our operations are subject to periodic renewal and may be revoked or modified
for cause or when new or revised environmental requirements are implemented. Changing and
increasingly strict environmental requirements can affect the manufacturing, handling, processing,
distribution and use of our chemical products and, if so affected, our business and operations may
be materially and adversely affected. In addition, changes in environmental requirements may cause
us to incur substantial costs in upgrading or redesigning our facilities and processes, including
our waste treatment, storage, disposal and other waste handling practices and equipment.
A business risk inherent in chemical operations is the potential for personal injury and
property damage claims from employees, contractors and their employees and nearby landowners and
occupants. While we believe our business operations and facilities generally are operated in
compliance with all applicable environmental and health and safety requirements in all material
respects, we cannot be sure that past practices or future operations will not result in material
claims or regulatory action, require material environmental expenditures or result in exposure or
injury claims by employees, contractors or their employees or the public. Some risk of
environmental costs and liabilities is inherent in our operations and products, as it is with other
companies engaged in similar businesses.
In light of our historical expenditures and expected future results of operations and sources
of liquidity, we believe we will have adequate resources to conduct our operations in compliance
with applicable environmental, health and safety requirements. Nevertheless, we may be required to
make significant site and operational
9
STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
modifications that are not currently contemplated in order to
comply with changing facility permitting requirements and regulatory standards. Additionally, we
have incurred, and may continue to incur, a liability for investigation and cleanup of waste or
contamination at our own facilities or at facilities operated by third parties where we have disposed of waste. We continually review all estimates of potential environmental
liabilities, but we may not have identified or fully assessed all potential liabilities arising out
of our past or present operations or the amount necessary to investigate and remediate any
conditions that may be significant to us. Based on information available at this time and reviews
undertaken to identify potential exposure, we believe any amount reserved for environmental matters
is adequate to cover our potential exposure for clean-up costs.
Air emissions from our manufacturing facility in Texas City, Texas, or our Texas City
facility, are subject to certain permit requirements and self-implementing emission limitations and
standards under state and federal laws. Our Texas City facility is subject to the federal
governments June 1997 National Ambient Air Quality Standards, or NAAQS, which lowered the ozone
and particulate matter concentration thresholds for attainment. Our Texas City facility is located
in an area that the Environmental Protection Agency, or EPA, has classified as not having achieved
attainment under the NAAQS for ozone, either on a 1-hour or an 8-hour basis. Ozone is typically
controlled by reduction of emissions of volatile organic compounds, or VOCs, and nitrogen oxide, or
NOx. The Texas Commission for Environmental Quality, or TCEQ, has imposed strict requirements on
regulated facilities, including our Texas City facility, to ensure that the air quality control
region will achieve attainment under the NAAQS for ozone. Local authorities may also impose new
ozone and particulate matter standards. Compliance with these stricter standards may substantially
increase our future control costs for emissions of NOx, VOCs and particulate matter, the amount and
full impact of which cannot be determined at this time.
In 2002, the TCEQ adopted a revised State Implementation Plan, or SIP, in order to achieve
compliance with the 1-hour ozone standard under the Clean Air Act by 2007. The EPA approved this
1-hour SIP, which required an 80% reduction of NOx emissions, and extensive monitoring of
emissions of highly reactive VOCs, or HRVOCs, such as ethylene, in the Houston-Galveston-Brazoria
area, or the HGB area. We are in full compliance with these regulations. However, the HGB area
failed to attain compliance with the 1-hour ozone standard, and Section 185 of the Clean Air Act
requires implementation of a program of emissions-based fees until the standard is attained. These
Section 185 fees will be assessed on all NOx and VOC emissions in 2008 and beyond in the HGB area
which are in excess of 80% of the baseline year. The method for calculating baseline emissions, as
well as other details of the program, has not yet been developed. At the present time, we do not
expect to be assessed any fees for our emissions for 2008, primarily due to the reduction in
emissions from our Texas City facility following the closure of our styrene facility.
In April 2004, the HGB area was designated a moderate non-attainment area with respect to
the 8-hour ozone standard of the Clean Air Act. However, in response to a request from the
Governor of Texas, the EPA has now reclassified the HGB area as a severe non-attainment area,
effective October 31, 2008. As a result, the new mandated compliance date for attainment of the
8-hour ozone standard is June 15, 2019. A revised 8-hour SIP to address the HGB areas severe
non-attainment designation will now have to be submitted to the EPA by April 10, 2010. The content
of the revised 8-hour SIP is unknown at this time making it difficult to predict our final cost of
compliance with these regulations. However, given the permanent shutdown of our phthalic anhydride
and styrene facilities, we do not anticipate incurring any further cost of compliance in connection
with the revised 8-hour SIP.
To reduce the risk of offsite consequences from unanticipated events, we acquired a greenbelt
buffer zone adjacent to our Texas City facility in 1991. We also participate in a regional air
monitoring network to monitor ambient air quality in the Texas City community.
Legal Proceedings:
On July 5, 2005, Patrick B. McCarthy, an employee of Kinder-Morgan, Inc., or Kinder-Morgan,
was seriously injured at Kinder-Morgans facilities near Cincinnati, Ohio, while attempting to
offload a railcar containing one of our plasticizers products. On October 28, 2005, Mr. McCarthy
and his family filed a suit in the Court of Common Pleas, Hamilton County, Ohio (Case No. A0509
144) against us and six other defendants. Since that time, five of
the other defendants were dismissed from the case. The plaintiffs
sought in excess of $42 million in alleged
compensatory and punitive damages from the defendants in the aggregate. Closing arguments for this
case occurred during the first week of May 2009 and, on May 7,
2009, the jury found that we had not been negligent in connection
with the incident and rendered a take nothing verdict for the
plaintiffs. At this time, it is impossible to determine
whether the plaintiffs will appeal the verdict. We believe that all, or substantially all, of any
10
STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
liability imposed upon us as a result of this
suit and our related out-of-pocket costs and expenses will be covered by our insurance policies,
subject to a $1 million deductible, which was met in January 2008. We do not believe that this
incident will have a material adverse effect on our business, financial condition, results of
operations or cash flows, although we cannot guarantee that a material adverse effect will not
occur.
On February 21, 2007, we received a summons naming us, several benefit plans and the plan
administrators for those plans as defendants in a class action suit, Case No. H-07-0625 filed in
the United States District Court, Southern District of Texas, Houston Division. The plaintiffs are
seeking to represent a proposed class of retired employees of Sterling Fibers, Inc., one of our
former subsidiaries that we sold in connection with our emergence from bankruptcy in 2002. The
plaintiffs are alleging that we were not permitted to increase their premiums for retiree medical
insurance based on a provision contained in the asset purchase agreement between us and Cytec
Industries Inc. and certain of its affiliates governing our purchase of our former acrylic fibers
business in 1997. During our bankruptcy case, we specifically rejected this asset purchase
agreement and the bankruptcy court approved that rejection. The plaintiffs are claiming that we
violated the terms of the benefit plans and breached fiduciary duties governed by the Employee
Retirement Income Security Act and are seeking damages, declaratory relief, punitive damages and
attorneys fees. The parties expect to complete discovery in the next few months. The plaintiffs
moved for partial summary judgment and for class certification related to their claims for denial
of benefits under our retiree medical plans. The defendants filed a cross-motion for summary
judgment on the denial of the benefits claim. The court certified the class of plaintiffs for the
denial of benefits claim, but denied both motions for summary judgment and identified issues for
trial. Trial for this matter is currently scheduled for September 2009. We are vigorously
defending this action and are unable to state at this time if a loss is probable or remote and are
unable to determine the possible range of loss related to this matter, if any.
On February 4, 2008, we filed a Petition for Declaratory Judgment in the 212th District Court
of Galveston County, Texas (Case #08CV0108) against Marathon Petroleum Company LLC, or Marathon, in
connection with a dispute between Marathon and us under a Purchase Agreement for FCC Off-Gas, or
the Off-Gas Purchase Agreement. Under the Off-Gas Purchase Agreement, we purchase an amount of
off-gas each month from Marathon within a stated range at Marathons option. Following the closure
of certain production units at our Texas City facility, our demand for off-gas has been below the
low-end of the stated range. On July 31, 2007, and again on November 19, 2007, we invoked the
contracts undue economic hardship clause and requested that Marathon enter into good faith
negotiations to modify the terms of the Off-Gas Purchase Agreement. After Marathon disputed the
applicability of the economic hardship provision and refused to renegotiate the terms of the
Off-Gas Purchase Agreement, we filed a declaratory judgment action to enforce the terms of the
economic hardship provision, and Marathon counter-claimed against us for breach of contract.
Significant discovery has occurred in connection with this matter and, on February 3, 2009, the
parties engaged in an unsuccessful mediation for this case. This matter is scheduled for trial in
October 2009. At this time, it is not possible to determine what, if any, liability we will have
under Marathons counter-claim and we are vigorously pursuing our declaratory judgment filing and
defending against Marathons counter-claim. We do not believe that this matter will have a
material adverse impact on our business, financial condition, results of operations or cash flows,
although we cannot guarantee that a material adverse effect will not occur.
On March 4, 2008, Gulf Hydrogen and Energy, L.L.C., or Gulf Hydrogen, filed suit against us in
the 212th District Court of Galveston County, Texas (Cause No. 08CV0220) to enforce the provisions
of a Memorandum of Understanding entered into between us and Gulf Hydrogen involving the possible
sale of our outstanding equity interests to Gulf Hydrogen for approximately $390 million. The
parties entered into a confidential settlement agreement in March 2009 and the lawsuit was
dismissed with prejudice by all parties. This matter did not have a material adverse affect on our
business, financial condition, results of operations or cash flows.
We are subject to various other claims and legal actions that arise in the ordinary course of
our business. We do not believe that any of these claims and actions, separately or in the
aggregate, will have a material adverse effect on our business, financial condition, results of
operations or cash flows, although we cannot guarantee that a material adverse effect will not
occur.
As we believe the potential for an unfavorable outcome regarding one or more of the matters
described above is probable, in accordance with SFAS No. 5, Accounting for Contingencies, we have
accrued a $1.0 million litigation reserve during 2008.
As of December 31, 2008, we had a receivable of $1.3 million due from our insurance carriers
for reimbursement of legal costs that exceeded our insurance deductibles and are therefore
reimbursable through our insurance carriers. For the quarter ended March 31, 2009, we incurred
$1.3 million of legal costs. We received $0.1
11
STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
million of payments in the first quarter of 2009
resulting in a balance of $2.5 million as of March 31, 2009, $0.2 million of which was paid in
April 2009.
5. Income Taxes
During the first quarters of 2009 and 2008, we recorded a net tax benefit of $0.2 million and
zero, respectively, for income taxes from continuing operations. Due to interim reporting, our
continuing operations effective tax rate is 24.76% for the period ending March 31, 2009 compared to
an effective tax rate of zero for the period ending March 31, 2008. The allocation of the tax
benefit to continuing operations reflects the effect of utilizing income in discontinued operations
to recognize a portion of the benefit from losses generated in continuing operations. This resulted in no change to the
valuation allowance of $52.0 million. For year
end, we expect to have a net effective tax rate of zero.
6. Pension Plans and Other Postretirement Benefits
Net periodic pension costs (benefits) consisted of the following components:
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in Thousands) |
|
Interest cost |
|
$ |
1,828 |
|
|
$ |
1,788 |
|
Expected return on plan assets |
|
|
(1,513 |
) |
|
|
(2,148 |
) |
Amortization |
|
|
864 |
|
|
|
2 |
|
|
|
|
|
|
|
|
Net pension cost (benefit) |
|
$ |
1,179 |
|
|
$ |
(358 |
) |
|
|
|
|
|
|
|
Other postretirement costs (benefits) consisted of the following components:
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in Thousands) |
|
Service cost |
|
$ |
11 |
|
|
$ |
3 |
|
Interest cost |
|
|
121 |
|
|
|
28 |
|
Amortization of unrecognized costs |
|
|
(541 |
) |
|
|
(106 |
) |
|
|
|
|
|
|
|
Net plan benefit |
|
$ |
(409 |
) |
|
$ |
(75 |
) |
|
|
|
|
|
|
|
7. Operating Segment and Sales Information
We report our operations through two segments: acetic acid and plasticizers. The critical
accounting policies for these operating segments are the same as those disclosed in our Annual
Report. We use gross profit for reporting the results of our operating segments and this measure
includes all operating items related to the businesses. There are no sales between segments. The
revenues and gross profit for each of our reportable operating segments are as follows:
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in Thousands) |
|
Revenues: |
|
|
|
|
|
|
|
|
Acetic acid |
|
$ |
23,838 |
|
|
$ |
28,977 |
|
Plasticizers |
|
|
7,284 |
|
|
|
9,011 |
|
Other |
|
|
255 |
|
|
|
270 |
|
|
|
|
|
|
|
|
Total |
|
$ |
31,377 |
|
|
$ |
38,258 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment gross profit: |
|
|
|
|
|
|
|
|
Acetic acid |
|
$ |
4,574 |
|
|
$ |
3,944 |
|
Plasticizers |
|
|
1,323 |
|
|
|
1,908 |
|
Other(1) |
|
|
(329 |
) |
|
|
(1,479 |
) |
|
|
|
|
|
|
|
Gross profit |
|
|
5,568 |
|
|
|
4,373 |
|
12
STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in Thousands) |
|
Selling, general and administrative expenses |
|
|
3,883 |
|
|
|
2,418 |
|
Interest and debt related expenses |
|
|
4,003 |
|
|
|
4,213 |
|
Interest income |
|
|
(384 |
) |
|
|
(1,326 |
) |
Other income |
|
|
(1,145 |
) |
|
|
|
|
|
|
|
|
|
|
|
Loss from continuing operations before income tax |
|
$ |
(789 |
) |
|
$ |
(932 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization expenses: |
|
|
|
|
|
|
|
|
Acetic acid |
|
$ |
1,643 |
|
|
$ |
1,512 |
|
Plasticizers |
|
|
312 |
|
|
|
532 |
|
Other(2) |
|
|
290 |
|
|
|
591 |
|
|
|
|
|
|
|
|
Total |
|
$ |
2,245 |
|
|
$ |
2,635 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures: |
|
|
|
|
|
|
|
|
Acetic acid |
|
$ |
1,455 |
|
|
$ |
800 |
|
Plasticizers |
|
|
|
|
|
|
|
|
Otherplant infrastructure |
|
|
987 |
|
|
|
1,237 |
|
|
|
|
|
|
|
|
Total |
|
$ |
2,442 |
|
|
$ |
2,037 |
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Gross loss for Other includes various unallocated corporate charges and credits. |
|
(2) |
|
Includes depreciation and amortization expense of less than $0.1 million and
$0.3 million for discontinued operations for the three months ended March 31,
2009 and 2008, respectively. |
|
|
|
|
|
|
|
|
|
|
|
March 31, 2009 |
|
|
December 31, 2008 |
|
|
|
(Dollars in Thousands) |
|
Total assets: |
|
|
|
|
|
|
|
|
Acetic acid |
|
$ |
33,140 |
|
|
$ |
40,707 |
|
Plasticizers |
|
|
6,425 |
|
|
|
6,311 |
|
Other(3) |
|
|
224,477 |
|
|
|
216,011 |
|
|
|
|
|
|
|
|
Total |
|
$ |
264,042 |
|
|
$ |
263,029 |
|
|
|
|
|
|
|
|
|
|
|
(3) |
|
Components of Other
are presented in
the table below: |
|
|
|
|
|
|
|
|
|
|
|
March 31, 2009 |
|
|
December 31, 2008 |
|
|
|
(Dollars in Thousands) |
|
Other: |
|
|
|
|
|
|
|
|
Corporate: |
|
|
|
|
|
|
|
|
Cash |
|
$ |
163,065 |
|
|
$ |
156,126 |
|
Other |
|
|
17,895 |
|
|
|
17,989 |
|
Plant infrastructure: |
|
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
43,371 |
|
|
|
41,730 |
|
Assets of discontinued operations |
|
|
146 |
|
|
|
166 |
|
|
|
|
|
|
|
|
Total |
|
$ |
224,477 |
|
|
$ |
216,011 |
|
|
|
|
|
|
|
|
13
STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
Sales to major customers constituting 10% or more of total revenues from continuing operations
were as follows (there were no export sales):
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
|
2009 |
|
2008 |
|
|
(Dollars in Thousands) |
Major customers: |
|
|
|
|
|
|
|
|
BP Chemicals |
|
$ |
23,838 |
|
|
$ |
28,977 |
|
BASF Corporation |
|
|
7,284 |
|
|
|
9,011 |
|
8. New Accounting Standards
Adoption of Accounting Standards:
In December 2007, the FASB issued SFAS No. 141 (revised 2007), Business Combinations, or
SFAS No. 141R. SFAS No. 141R broadens the guidance of SFAS No. 141, extending its applicability to
all transactions and other events in which one entity obtains control over one or more other
businesses. SFAS No. 141R broadens the fair value measurement and recognition of assets acquired,
liabilities assumed and interests transferred as a result of business combinations, and expands on
required disclosures to improve the statement users abilities to evaluate the nature and financial
effects of business combinations. We implemented SFAS No. 141R effective January 1, 2009 and it
did not have a material impact on our condensed consolidated financial statements.
In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated
Financial Statements; an Amendment of ARB No. 51, or SFAS No. 160. SFAS No. 160 establishes the
accounting and reporting standards for a noncontrolling interest in a subsidiary and for the
deconsolidation of a subsidiary and clarifies that a noncontrolling interest in a subsidiary is an
ownership interest in the consolidated entity that should be reported as equity in the consolidated
financial statements. SFAS No. 160 requires retroactive adoption of the presentation and
disclosure requirements for existing minority interests and applies prospectively to business
combinations for fiscal years beginning after December 15, 2008. We implemented SFAS No. 160
effective January 1, 2009 and it did not have a material impact on our condensed consolidated
financial statements.
In March 2008, the FASB issued SFAS No. 161, Disclosures About Derivative Instruments and
Hedging Activities, or SFAS No. 161. SFAS No. 161 requires enhanced disclosures about an entitys
derivative and hedging activities, with the intent to provide users of financial statements with an
enhanced understanding of (a) how and why an entity uses derivative instruments, (b) how derivative
instruments and related hedged items are accounted for under SFAS No. 133, Accounting for
Derivative Instruments and Hedging Activities, and its related interpretations and (c) how
derivative instruments and related hedged items affect an entitys financial position, financial
performance and cash flows. We implemented SFAS No. 161 effective January 1, 2009 and it did not
have a material impact on our condensed consolidated financial statements.
In May 2008, the FASB issued SFAS No. 162, The Hierarchy of Generally Accepted Accounting
Principles, or SFAS No. 162. SFAS No. 162 identifies the sources of accounting principles and the
framework for selecting the principles to be used in the preparation of financial statements that
are presented in conformity with generally accepted accounting principles in the United States. We
implemented SFAS No. 162 effective January 1, 2009 and it did not have a material impact on our
condensed consolidated financial statements.
In April 2009, the FASB issued FASB Staff Position SFAS No. 141(R)-1, Accounting for Assets
Acquired and Liabilities Assumed in a Business Combination that Arise from Contingencies, or FSP
No. 141(R)-1. FSP No. 141(R)-1 applies to all assets acquired and all liabilities assumed in a
business combination that arise from contingencies. FSP No. 141(R)-1 requires the acquirer to
recognize such an asset or liability if the acquisition-date fair value of that asset or liability
can be determined during the measurement period. If it cannot be determined during the measurement
period, then the asset or liability should be recognized at the acquisition date if, consistent
with SFAS No. 5, Accounting for Contingencies, information available before the end of the
measurement period indicates that it is probable that an asset existed or that a liability had been
incurred at the acquisition date, and the amount of the asset or liability can be reasonably
estimated. We implemented FSP No. 141(R)-1 effective January 1, 2009 and it did not have a
material impact on our condensed consolidated financial statements.
14
STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
Future Adoption of Accounting Standards:
In December 2008, the FASB issued FASB Staff Position SFAS No.132(R)-1, Employers
Disclosures about Pensions and Other Postretirement Benefits, or FSP No. 132R-1. FSP No. 132R-1
requires enhanced disclosures about the plan assets of defined benefit pension and other
postretirement plans. The enhanced disclosures required by FSP No. 132R-1 are intended to provide
users of financial statements with a greater understanding of (a) how investment allocation
decisions are made, including the factors that are pertinent to an understanding of investment
policies and strategies, (b) the major categories of plan assets, (c) the inputs and valuation
techniques used to measure the fair value of plan assets, (d) the effect of fair value measurements
using significant unobservable inputs (Level 3) on changes in plan assets for the period and (e)
significant concentrations of risk within plan assets. FSP No. 132R-1 is effective for the year
ending December 31, 2009. We do not believe the implementation of FSP No. 132R-1 will have a
material impact on our consolidated financial statements.
In April 2009, the FASB issued FASB Staff Position SFAS No. 107-1 and Accounting Principles
Board No. 28-1, Interim Disclosures about Fair Value of Financial Instruments, or FSP No. 107-1.
FSP No. 107-1 requires the disclosure of the fair value of financial instruments for interim
reporting periods of publicly traded companies as well as in the annual financial statements. FSP
No. 107-1 is effective for interim reporting periods ending after June 15, 2009 with early adoption
permitted for periods ending after March 15, 2009. We do not expect the adoption of FSP No. 107-1
to have a material impact on our condensed consolidated financial statements.
In April 2009, the FASB issued FASB Staff Position SFAS No. 115-2 and SFAS No. 124-2,
Recognition and Presentation of Other-Than-Temporary Impairments, or FSP Nos. 115-2 and 124-2,
which provide new guidance on the recognition of other-than-temporary impairments of investments in
debt securities and provide new presentation and disclosure requirements for other-than-temporary
impairments of investments in debt and equity securities. FSP Nos. 115-2 and 124-2 are effective
for our quarter ending June 30, 2009. We do not expect the adoption of FSP Nos. 115-2 and 124-2 to
have a material impact on our condensed consolidated financial statements.
15
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in conjunction with our condensed consolidated
financial statements (including the Notes thereto) included in Item 1, Part I of this report.
Business Overview
We are a North American producer of selected petrochemicals used to manufacture a wide array
of consumer goods and industrial products. We currently operate in two segments: acetic acid and
plasticizers. Each segment has a single customer.
Our acetic acid is used primarily to manufacture vinyl acetate monomer, which is used in a
variety of products, including adhesives and surface coatings. Pursuant to our Acetic Acid
Production Agreement that extends to 2031, all of our acetic acid production is sold to BP Amoco
Chemicals Company, or BP Chemicals. We are BP Chemicals sole source of acetic acid production in
the Americas. BP Chemicals markets all of the acetic acid that we produce and pays us, among other
amounts, a portion of the profits derived from its sales of our acetic acid. In addition, BP
Chemicals reimburses us for 100% of our fixed and variable costs of production, other than
specified indirect costs. We also jointly invest with BP Chemicals in capital expenditures related
to our acetic acid facility in the same percentage as the profits from the business we receive from
BP Chemicals.
We own and operate one of the lowest cost acetic acid facilities in the world. Our acetic
acid facility utilizes BP Chemicals proprietary Cativa carbonylation technology, which we
believe offers several advantages over competing production methods, including lower energy
requirements and lower fixed and variable costs. Acetic acid production has two major raw material
requirements, methanol and carbon monoxide. BP Chemicals, a producer of methanol, supplies 100% of
our methanol requirements related to our production of acetic acid. All of our requirements for
carbon monoxide are supplied by Praxair Hydrogen Supply, Inc., or Praxair, from a partial oxidation
unit constructed by Praxair on land leased from us at our site in Texas City, Texas, or our Texas
City facility.
Although recent slowdowns in the housing and automotive markets are reducing short-term global
demand for vinyl acetate monomer, the largest derivative of acetic acid, annual global production
of vinyl acetate monomer is expected to increase from 10.4 billion pounds in 2005 to 12.2 billion
pounds in 2010. The North American acetic acid industry tends to sell most of its products through
long-term sales agreements having cost plus pricing mechanisms, eliminating much of the
volatility seen in other petrochemicals products and resulting in more stable and predictable
earnings and profit margins.
All of our plasticizers, which are used to make flexible plastics, such as shower curtains,
floor coverings, automotive parts and construction materials, are sold to BASF Corporation, or
BASF, pursuant to a long-term production agreement that extends until 2013, subject to some early
termination rights held by BASF that begin in 2010. Under our agreement with BASF, or our
Plasticizers Production Agreement, BASF provides us with most of the required raw materials,
markets the plasticizers that we produce and is obligated to make certain fixed quarterly payments
to us while reimbursing us monthly for our actual production costs and capital expenditures
relating to our plasticizers facility. Due to the contract terms in our Plasticizers Production
Agreement with BASF, we are not exposed to fluctuations in costs or market conditions. Our
Plasticizers Production Agreement was amended in May 2008 after BASF nominated zero pounds of
phthalic anhydride, or PA, under the prior version of the agreement due to deteriorating market
conditions which ultimately resulted in the closure of our PA unit.
On September 17, 2007, we entered into a long-term exclusive styrene supply agreement and a
related railcar purchase and sale agreement with NOVA Chemicals Inc., which as subsequently
assigned to INEOS NOVA, LLC, or INEOS NOVA. After the supply agreement became effective, INEOS
NOVA nominated zero pounds of styrene under the supply agreement for the balance of 2007 and, in
response, we exercised our right to terminate the supply agreement and permanently shut down our
styrene facility. Under the supply agreement, we are responsible for the closure costs of our
styrene facility and are also restricted from reentering the styrene business until November 2012.
The restricted period was initially eight years. However, on April 1, 2008, INEOS NOVA
unilaterally reduced the restricted period to five years.
16
We sold substantially all remaining styrene inventory during the first quarter of 2008. The
decommissioning process was completed by the end of 2008 and the associated costs incurred for 2007
and 2008 were $0.7 million and $18.9 million, respectively. In July 2008, we announced a reduction
in work force in order to reduce our staffing to a level appropriate for our existing operations
and site development projects. As a result, we reduced our salaried work force by 19 people and
our hourly work force by 15 people. In accordance with Statement of Financial Accounting
Standards, or SFAS, No. 146, Accounting for Costs Associated with Exit or Disposal Activities, we
recognized and paid $1.4 million of severance costs in 2008. Additionally, as a result of our work
force reduction, we recorded a curtailment loss of $1.2 million for our benefit plans in accordance
with SFAS No. 88, Employers Accounting for Settlements and Curtailments of Defined Benefit
Pension Plans and for Termination Benefits, in 2008.
We own the acetic acid and plasticizers manufacturing units located at our Texas City
facility. We lease a portion of our Texas City facility to Praxair, who constructed a partial
oxidation unit on that land. We also lease a portion of our Texas City facility to S&L
Cogeneration Company, a 50/50 joint venture between us and Praxair Energy Resources, Inc., or
Praxair Energy, who constructed a cogeneration facility on that land. However, as our strategic
initiatives under consideration do not require utilization of the steam produced by the
cogeneration facility, we and Praxair Energy elected to terminate the joint venture and the Joint
Venture Agreement governing S&L Cogeneration Company, or the Joint Venture Agreement, was amended
to extend its term until June 30, 2009, to address several matters related to the sale of the
cogeneration facility, the distribution of S&L Cogeneration Companys assets and the termination
and winding-up of the joint venture. We lease space for our principal offices located in Houston,
Texas. We operate in two segments: acetic acid and plasticizers.
Results of Operations
Three Months Ended March 31, 2009 Compared to Three Months Ended March 31, 2008
Revenues and net loss from continuing operations
Our
revenues were $31.4 million for the first quarter of 2009, an
18% decrease from the $38.3
million in revenues we recorded for the first quarter of 2008. We had a net loss from continuing
operations of $0.6 million for the first quarter of 2009, compared to a net loss from continuing
operations of $0.9 million in the first quarter of 2008.
Revenues
from our acetic acid operations were approximately $23.8 million in the first quarter
of 2009, an 18% decrease from the $29.0 million in revenues from these operations in the first
quarter of 2008. This decrease in acetic acid revenues in the first quarter of 2009 was primarily
due to an approximate $6.0 million decrease in cost reimbursements from BP Chemicals as a result of
lower energy costs in the first quarter of 2009 compared to the first quarter of 2008, slightly
offset by higher profit sharing revenue of approximately $0.9 million. Gross profit for our acetic
acid operations was $4.6 million for the first quarter of 2009
compared to $3.9 million for the
first quarter of 2008. The increase in profit sharing revenue and gross profit was primarily due
to higher margins on acetic acid sales for the first quarter of 2009 compared to the first quarter
of 2008, partially offset by lower sales volumes.
Revenues
from our plasticizers operations were approximately $7.3 million in the first quarter
of 2009, a 19% decrease from the $9.0 million in revenues from these operations in the first
quarter of 2008. Gross profit from our plasticizers operations was
$1.3 million for the first
quarter of 2009 compared to $1.9 million for the first quarter of 2008. This decrease in revenues
and gross profit is primarily due to a reimbursement by BASF of $1.4 million for cost savings
achieved during prior periods that were approved and paid by BASF in the first quarter of 2008.
Selling, general and administrative expenses
Our selling, general and administrative expenses were $3.9 million for the first quarter of
2009 compared to $2.4 million for the first quarter of 2008. This increase in 2009 was primarily
due to increased legal fees of $0.8 million resulting from the lawsuits described in Note 4 to the
condensed consolidated financial statements included in Item 1 of Part 1 of this report, and $0.3
million of expenses incurred in the first quarter of 2009 for strategic initiatives we are
pursuing.
Other income expense
17
We recorded $1.1 million of insurance proceeds in the first quarter of 2009 for reimbursement
of legal fees incurred in excess of our deductibles under our various insurance policies. As of
March 31, 2009, we have an insurance reimbursement receivable of $2.5 million. There were no such
legal fee reimbursements in the first quarter of 2008.
Interest income
We recorded $0.4 million of interest income in the first quarter of 2009 compared to $1.3
million in the first quarter of 2008. This decrease was due to lower interest rates earned on our
cash investments in 2009 compared to 2008.
Benefit for income taxes
During
the first quarters of 2009 and 2008, we recorded a net tax benefit of
$0.2 million and
zero, respectively, for income taxes from continuing operations. Due to interim reporting, our
continuing operations effective tax rate is 24.76% for the period ending March 31, 2009 compared to
an effective tax rate of zero for the period ending March 31, 2008. The allocation of the tax
benefit to continuing operations reflects the effect of utilizing income in discontinued operations
to recognize a portion of the benefit from losses generated in continuing operations. This resulted in no change to the
valuation allowance of $52.0 million. For year
end, we expect to have a net effective tax rate of zero.
Income (loss) from discontinued operations
During
the first quarter of 2009, net income from discontinued operations
was $1.6 million
compared to a net loss of $6.3 million for the first quarter of 2008. This improvement was
primarily due to costs incurred for decommissioning our styrene facility in 2008 as a result of our
exit from the styrene business in late 2007.
Liquidity and Capital Resources
On March 29, 2007, we completed a private offering of $150 million aggregate principal amount
of unregistered 101/4% Senior Secured Notes due 2015, or our Secured Notes, pursuant to a Purchase
Agreement among us, Sterling Chemicals Energy, Inc., or Sterling Energy, one of our former
wholly-owned subsidiaries, and Jefferies & Company, Inc. and CIBC World Markets Corp., as initial
purchasers. In connection with that offering, we entered into an indenture, dated March 29, 2007,
among us, Sterling Energy, as guarantor, and U. S. Bank National Association, as trustee and
collateral agent. On May 6, 2008, Sterling Energy was merged with and into us. Upon consummation
of the merger, Sterling Energy no longer had independent existence and, consequently, our Secured
Notes are no longer guaranteed by Sterling Energy. Pursuant to a registration rights agreement
among us, Sterling Energy and the initial purchasers, we agreed to exchange our unregistered
Secured Notes for a new issue of substantially identical debt securities registered under the
Securities Act, to cause the registration statement for the exchange offer to become effective by
December 24, 2007, and to complete the exchange offer within 50 days of the effective date of the
registration statement. On August 30, 2007, we made an initial filing of the exchange offer
registration statement. However, the registration statement was not declared effective by December
24, 2007, and, as a result, the interest rate on our Secured Notes increased by 0.25% per annum on
each of December 25, 2007, March 24, 2008 and June 22, 2008. The registration statement was
declared effective on August 13, 2008, and the exchange offer was closed on September 19, 2008. As
a result, the interest rate on our Secured Notes reverted back to the face amount of 101/4% per annum
when the exchange offer closed. The additional interest incurred from December 25, 2007 through
the closing of the exchange offer was approximately $0.5 million and was paid on April 1 and
October 1, 2008.
Our indenture contains affirmative and negative covenants and customary events of default,
including payment defaults, breaches of covenants and certain events of bankruptcy, insolvency and
reorganization. If an event of default occurs and is continuing, other than an event of default
triggered upon certain bankruptcy events, the trustee under our indenture or the holders of at
least 25% in principal amount of our outstanding Secured Notes may declare our Secured Notes to be
due and payable immediately. Upon an event of default, the trustee may also take actions to
foreclose on the collateral securing our outstanding Secured Notes, subject to the terms of an
intercreditor agreement
18
dated March 29, 2007, among us, Sterling Energy, the trustee and The CIT Group/Business
Credit, Inc. Our indenture does not require us to maintain any financial ratios or satisfy any
financial maintenance tests. We are currently in compliance with all of the covenants contained in
our indenture.
Interest is due on our outstanding Secured Notes on April 1 and October 1 of each year. Our
outstanding Secured Notes, which mature on April 1, 2015, are senior secured obligations and rank
equally in right of payment with all of our existing and future senior indebtedness. Subject to
specified permitted liens, our outstanding Secured Notes are secured (i) on a first priority basis,
by all of our fixed assets and certain related assets, including, without limitation, all property,
plant and equipment and (ii) on a second priority basis, by our other assets, including, without
limitation, accounts receivable, inventory, capital stock of our domestic restricted subsidiaries,
intellectual property, deposit accounts and investment property.
On December 19, 2002, we entered into a Revolving Credit Agreement, or our revolving credit
facility, with The CIT Group/Business Credit, Inc., as administrative agent and a lender, and
certain other lenders. Under our revolving credit facility, we and Sterling Energy were
co-borrowers and were jointly and severally liable for any indebtedness thereunder. After the
merger of Sterling Energy with and into us, Sterling Energy ceased to be a co-borrower under our
revolving credit facility. Our revolving credit facility is secured by first priority liens on all
of our accounts receivable, inventory and other specified assets. On March 29, 2007, we amended
and restated our revolving credit facility to, among other things, extend the term of our revolving
credit facility until March 29, 2012, reduce the maximum commitment thereunder to $50 million, make
certain changes to the calculation of the borrowing base and lower the interest rates and fees
charged thereunder. Borrowings under our revolving credit facility bear interest, at our option,
at an annual rate of a base rate plus 0.0% to 0.50% or the LIBOR rate plus 1.50% to 2.25%,
depending on our borrowing availability at the time. We are also required to pay an aggregate
commitment fee of 0.375% per year (payable monthly) on any unused portion of our revolving credit
facility. Available credit under our revolving credit facility is subject to a monthly borrowing
base of 70% of eligible accounts receivable plus 65% of eligible inventory. In response to the
expected continued lower levels of accounts receivable and inventory, as well as our lesser need
for a working capital facility, we reduced our commitment under our revolving credit facility to
$25 million on June 30, 2008. On November 7, 2008, we further amended our revolving credit
facility to substantially reduce restrictions, subject to minimum liquidity requirements, on
investment of cash and other assets, payment of cash dividends, repurchase of debt and equity
securities, modification of preferred stock terms, entry into affiliated transactions, disposition
of assets and engagement in certain business activities. We paid the administrative agent an
amendment fee plus expenses totaling approximately $0.1 million in connection with this amendment.
As of March 31, 2009, total credit available under our revolving credit facility was limited
to $10.1 million, there were no loans outstanding and we had $3.9 million in letters of credit
outstanding, resulting in borrowing availability of $6.2 million. Pursuant to Emerging Issues Task
Force Issue No. 95-22, Balance Sheet Classification of Borrowings under Revolving Credit
Agreements That Include both a Subjective Acceleration Clause and a Lock-Box Arrangement, any
balances outstanding under our revolving credit facility would be classified as a current portion
of long-term debt.
Our revolving credit facility contains numerous covenants and conditions, including, but not
limited to, restrictions on our ability to incur indebtedness, create liens, sell assets, make
investments of cash and other assets, make capital expenditures, engage in mergers and acquisitions
and pay cash dividends. Our revolving credit facility also includes various circumstances and
conditions that would, upon their occurrence and subject in certain cases to notice and grace
periods, create an event of default thereunder. Our revolving credit facility does not require us
to maintain any financial ratios or satisfy any financial maintenance tests. We are currently in
compliance with all of the covenants contained in our revolving credit facility.
Our liquidity (i.e., cash and cash equivalents plus total credit available under our revolving
credit facility) was $169.3 million at March 31, 2009, an increase of $2.1 million compared to our
liquidity at December 31, 2008. This increase was primarily due to acetic acid profit sharing
payments for 2008 received from BP Chemicals during the first quarter of 2009.
Recent distress in the financial markets has had an adverse impact on financial market
activities including, among other things, volatility in security prices, diminished liquidity and
credit availability, rating downgrades of
19
certain investments and declining valuations of others. We have assessed the implications of
these factors on our current business and determined that there has not been a significant impact
to our financial condition, results of operations or liquidity during the first quarter of 2009.
Our cash is invested in highly rated money market funds, which are guaranteed by the US Department
of Treasury under its Temporary Guarantee Program for Money Market Funds. We believe that our cash
on hand and cash generated from continuing operations, along with credit available under our
revolving credit facility, will be sufficient to meet our short-term and long-term liquidity needs
for the reasonably foreseeable future.
Working Capital
Our
working capital was $144.1 million as of March 31, 2009, a
decrease of $1.9 million from
our working capital of $146.0 million as of December 31, 2008.
Cash Flow
Net cash provided by operations was $9.3 million for the first three months of 2009, compared
to $72.3 million during the first three months of 2008. This decrease in net cash flow provided by
operations during the first three months of 2009 was primarily due to the monetization of our
styrene working capital of approximately $67.0 million in 2008. Net cash flow used in investing
activities increased to $2.4 million during the first three months of 2009, compared to $2.0
million for the first three months of 2008, and such increase was due to increased capital
expenditures. There was no cash flow provided by financing activities in either the first three
months of 2009 or 2008.
Capital Expenditures
Our capital expenditures were $2.4 million during the first three months of 2009 compared to
$2.0 million during the first three months of 2008. We expect our capital expenditures for the
remainder of 2009 to be approximately $10.1 million, including $0.8 million for a capital project
to prevent the discharge of process wastewater during periods of heavy rain at our Texas City
facility and $3.3 million for our portion of acetic acid related projects, including construction
of an acetic acid pipeline and other replacement and debottlenecking projects. The remaining $6.0
million is primarily for routine safety, environmental, replacement capital and profit improvement
projects.
Contractual Cash Obligations
As of March 31, 2009, there have been no significant changes to the contractual obligations
disclosed in our Annual Report.
Critical Accounting Policies, Use of Estimates and Assumptions
The preparation of financial statements in conformity with generally accepted accounting
principles requires management to make estimates and assumptions that affect the amounts reported
in the condensed consolidated financial statements and related notes. Actual results could differ
from those estimates. On an ongoing basis, we review our estimates, including those related to the
allowance for doubtful accounts, recoverability of long-lived assets, deferred tax asset valuation
allowance, litigation, environmental liabilities, pension and
post-retirement benefits, preferred stock dividends and various
other operating allowances and accruals, based on currently available information. Changes in
facts and circumstances may alter such estimates and affect our results of operations and financial
position in future periods. There have been no material changes or developments in our evaluation
of the accounting estimates or the underlying assumptions or methodologies that we believe to be
critical accounting policies disclosed in our Annual Report.
New Accounting Standards
Adoption of Accounting Standards:
In December 2007, the FASB issued SFAS No. 141 (revised 2007), Business Combinations, or
SFAS No. 141R. SFAS No. 141R broadens the guidance of SFAS No. 141, extending its applicability to
all transactions and other events in which one entity obtains control over one or more other
businesses. SFAS No. 141R broadens the fair value measurement and recognition of assets acquired,
liabilities assumed and interests transferred as a result of business combinations, and expands on
required disclosures to improve the statement users abilities to evaluate the
20
nature and financial effects of business combinations. We implemented SFAS No. 141R effective
January 1, 2009 and it did not have a material impact on our condensed consolidated financial
statements.
In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated
Financial Statements; an Amendment of ARB No. 51, or SFAS No. 160. SFAS No. 160 establishes the
accounting and reporting standards for a noncontrolling interest in a subsidiary and for the
deconsolidation of a subsidiary and clarifies that a noncontrolling interest in a subsidiary is an
ownership interest in the consolidated entity that should be reported as equity in the consolidated
financial statements. SFAS No. 160 requires retroactive adoption of the presentation and
disclosure requirements for existing minority interests and applies prospectively to business
combinations for fiscal years beginning after December 15, 2008. We implemented SFAS No. 160
effective January 1, 2009 and it did not have a material impact on our condensed consolidated
financial statements.
In March 2008, the FASB issued SFAS No. 161, Disclosures About Derivative Instruments and
Hedging Activities, or SFAS No. 161. SFAS No. 161 requires enhanced disclosures about an entitys
derivative and hedging activities, with the intent to provide users of financial statements with an
enhanced understanding of (a) how and why an entity uses derivative instruments, (b) how derivative
instruments and related hedged items are accounted for under SFAS No. 133, Accounting for
Derivative Instruments and Hedging Activities, and its related interpretations and (c) how
derivative instruments and related hedged items affect an entitys financial position, financial
performance and cash flows. We implemented SFAS No. 161 effective January 1, 2009 and it did not
have a material impact on our condensed consolidated financial statements.
In May 2008, the FASB issued SFAS No. 162, The Hierarchy of Generally Accepted Accounting
Principles, or SFAS No. 162. SFAS No. 162 identifies the sources of accounting principles and the
framework for selecting the principles to be used in the preparation of financial statements that
are presented in conformity with generally accepted accounting principles in the United States. We
implemented SFAS No. 162 effective January 1, 2009 and it did not have a material impact on our
condensed consolidated financial statements.
In June 2008, the FASB issued FASB Staff Position Emerging Issues Task Force Determining
Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities, or
FSP EITF No. 03-6-1, which addresses whether instruments granted in share-based payment
transactions are participating securities prior to vesting and, therefore, need to be included in
earnings allocation in computing earnings per share under the two-class method as described in SFAS
No. 128, Earnings Per Share. Under the guidance in FSP EITF No. 03-6-1, unvested share-based
payment awards that contain non-forfeitable rights to dividends or dividend equivalents (whether
paid or unpaid) are participating securities and need to be included in the computation of earnings
per share pursuant to the two-class method. We implemented FSP EITF No. 03-6-1 effective January
1, 2009 and it did not have a material impact on our condensed consolidated financial statements.
In April 2009, the FASB issued FASB Staff Position SFAS No. 141(R)-1, Accounting for Assets
Acquired and Liabilities Assumed in a Business Combination that Arise from Contingencies, or FSP
No. 141(R)-1. FSP No. 141(R)-1 applies to all assets acquired and all liabilities assumed in a
business combination that arise from contingencies. FSP No. 141(R)-1 requires the acquirer to
recognize such an asset or liability if the acquisition-date fair value of that asset or liability
can be determined during the measurement period. If it cannot be determined during the measurement
period, then the asset or liability should be recognized at the acquisition date if, consistent
with SFAS No. 5, Accounting for Contingencies, information available before the end of the
measurement period indicates that it is probable that an asset existed or that a liability had been
incurred at the acquisition date, and the amount of the asset or liability can be reasonably
estimated. We implemented FSP No. 141(R)-1 effective January 1, 2009 and it did not have a
material impact on our condensed consolidated financial statements.
Future Adoption of Accounting Standards:
In December 2008, the FASB issued FASB Staff Position SFAS No.132(R)-1, Employers
Disclosures about Pensions and Other Postretirement Benefits, or FSP No. 132R-1. FSP No. 132R-1
requires enhanced disclosures about the plan assets of defined benefit pension and other
postretirement plans. The enhanced disclosures required by FSP No. 132R-1 are intended to provide
users of financial statements with a greater understanding of (a) how investment allocation
decisions are made, including the factors that are pertinent to an understanding of investment
policies and strategies, (b) the major categories of plan assets, (c) the inputs and valuation
techniques used to measure the fair value of plan assets, (d) the effect of fair value measurements
using significant unobservable inputs (Level 3) on changes in plan assets for the period and (e)
significant concentrations of risk within plan assets. FSP No. 132R-1 is effective for the year
ending December 31, 2009. We do not believe the implementation of FSP No. 132R-1 will have a
material impact on our consolidated financial statements.
21
In April 2009, the FASB issued FASB Staff Position SFAS No. 107-1 and Accounting Principles
Board No. 28-1, Interim Disclosures about Fair Value of Financial Instruments, or FSP No. 107-1.
FSP No. 107-1 requires the disclosure of the fair value of financial instruments for interim
reporting periods of publicly traded companies as well as in the annual financial statements. FSP
No. 107-1 is effective for interim reporting periods ending after June 15, 2009 with early adoption
permitted for periods ending after March 15, 2009. We do not expect the adoption of FSP No. 107-1
to have a material impact on our condensed consolidated financial statements.
In April 2009, the FASB issued FASB Staff Position SFAS No. 115-2 and SFAS No. 124-2,
Recognition and Presentation of Other-Than-Temporary Impairments, or FSP Nos. 115-2 and 124-2,
which provide new guidance on the recognition of other-than-temporary impairments of investments in
debt securities and provide new presentation and disclosure requirements for other-than-temporary
impairments of investments in debt and equity securities. FSP Nos. 115-2 and 124-2 are effective
for our quarter ending June 30, 2009. We do not expect the adoption of FSP Nos. 115-2 and 124-2 to
have a material impact on our condensed consolidated financial statements.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Our $150 million of Secured Notes bear interest at an annual rate of
101/4%, payable semi-annually on April 1 and October 1 of each year. The
fair value of our Secured Notes is based on their quoted price, which may vary in response to
changing interest rates. As of March 31, 2009, the fair value of our Secured Notes was
approximately $132.0 million.
Item 4T. Controls and Procedures
Evaluation of Disclosure Controls and Procedures. We maintain disclosure controls and procedures
(as defined in Rule 13a-15(e) of the Securities Exchange Act) designed to provide reasonable
assurance that the information required to be disclosed by us in the reports that we file or submit under
the Exchange Act is recorded, processed, summarized, and reported within the time periods specified
in the SECs rules and forms. These include controls and procedures designed to ensure that this
information is accumulated and communicated to our management, including our Chief Executive
Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding required
disclosure. Because of its inherent limitations, internal control over financial reporting may not
prevent or detect misstatements. Therefore, even those systems determined to be effective can provide
only reasonable assurance of achieving their control objectives. Our management, with the
participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the
effectiveness of our disclosure controls and procedures as of March 31, 2009. Based on this
evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our
disclosure controls and procedures were not effective as of March 31, 2009 due to the identification of
a control deficiency that represents a material weakness in our internal control over financial reporting.
This material weakness resulted from a lack of effective controls over the accounting for utilities at our
Texas City facility, specifically accounting for the flow of water throughout our facility. As a result of
the identification of this material weakness, our principal executive officer and principal financial
officer concluded that, as of March 31, 2009, our disclosure controls and procedures were not effective
pursuant to Exchange Act Rules 13a-15(f) and 15d-15(f).
Management is in the process of identifying the actions required to successfully remediate the
identified material weakness in our internal controls over financial reporting, which will include
supplementing our written policies and procedures to ensure we have a review and approval processes
in place between accounting and operational personnel while increasing the level of monitoring
controls. We anticipate that the remediation actions will be identified and implemented by the end of
the second quarter of 2009.
Notwithstanding our assessment that our internal controls over financial reporting were not effective
and our identification of the above-described material weakness, we believe that our financial
statements contained in this report on Form 10-Q for the quarter ended March 31, 2009, accurately
present our financial condition, results of operations and cash flows in all material respects.
Changes in Internal Control over Financial Reporting. There have been no changes in our internal
control over financial reporting for the quarter ended March 31, 2009, that have materially affected, or
are reasonably likely to materially affect, our internal control over financial reporting.
22
PART II.
OTHER INFORMATION
Item 1. Legal Proceedings
The information under Legal Proceedings in Note 4 to the condensed consolidated financial
statements included in Item 1 of Part I of this report is hereby incorporated by reference.
23
Item 6. Exhibits
The following are filed or furnished as part of this Form 10-Q:
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description of Exhibit |
|
|
|
|
|
*3.1
|
|
|
|
Certificate of Amendment to the Second Amended and Restated Certificate of
Incorporation of Sterling Chemicals, Inc. |
|
|
|
|
|
+*10.1
|
|
|
|
Second Amended and Restated 2002 Stock Plan. |
|
|
|
|
|
+10.2
|
|
|
|
2009 Bonus Plan (incorporated by reference to Exhibit 10.1 to our current
report on Form 8-K filed January 15, 2009). |
|
|
|
|
|
+*10.3 |
|
|
|
Sterling Chemicals, Inc. Eighth
Amended and Restated Savings and Investment Plan. |
|
|
|
|
|
*15.1
|
|
|
|
Letter of Grant Thornton LLP regarding unaudited interim financial information. |
|
|
|
|
|
*31.1
|
|
|
|
Rule 13a-14(a) Certification of the Chief Executive Officer. |
|
|
|
|
|
*31.2
|
|
|
|
Rule 13a-14(a) Certification of the Chief Financial Officer. |
|
|
|
|
|
*32.1
|
|
|
|
Section 1350 Certification of the Chief Executive Officer. |
|
|
|
|
|
*32.2
|
|
|
|
Section 1350 Certification of the Chief Financial Officer. |
|
|
|
* |
|
Filed or furnished herewith |
|
+ |
|
Management contract or compensatory plan or arrangement |
24
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the
Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly
authorized.
|
|
|
|
|
|
STERLING CHEMICALS, INC.
(Registrant)
|
|
Date: May 15, 2009 |
By |
/s/ JOHN V. GENOVA
|
|
|
|
John V. Genova |
|
|
|
President and Chief Executive Officer |
|
|
|
|
|
Date: May 15, 2009 |
By |
/s/ JOHN R. BEAVER
|
|
|
|
John R. Beaver |
|
|
|
Senior Vice President-Finance and
Chief Financial Officer
(Principal Financial Officer) |
|
25
EXHIBIT INDEX
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description of Exhibit |
|
|
|
|
|
*3.1
|
|
|
|
Certificate of Amendment to the Second Amended and Restated Certificate of
Incorporation of Sterling Chemicals, Inc. |
|
|
|
|
|
+*10.1
|
|
|
|
Second Amended and Restated 2002 Stock Plan. |
|
|
|
|
|
+10.2
|
|
|
|
2009 Bonus Plan (incorporated by reference to Exhibit 10.1 to our current
report on Form 8-K filed January 15, 2009). |
|
|
|
|
|
+*10.3 |
|
|
|
Sterling Chemicals, Inc. Eighth
Amended and Restated Savings and Investment Plan. |
|
|
|
|
|
*15.1
|
|
|
|
Letter of Grant Thornton LLP regarding unaudited interim financial information. |
|
|
|
|
|
*31.1
|
|
|
|
Rule 13a-14(a) Certification of the Chief Executive Officer. |
|
|
|
|
|
*31.2
|
|
|
|
Rule 13a-14(a) Certification of the Chief Financial Officer. |
|
|
|
|
|
*32.1
|
|
|
|
Section 1350 Certification of the Chief Executive Officer. |
|
|
|
|
|
*32.2
|
|
|
|
Section 1350 Certification of the Chief Financial Officer. |
|
|
|
* |
|
Filed or furnished herewith |
|
+ |
|
Management contract or compensatory plan or arrangement |
26